Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Obesity and Diabetes
Researchers at University Hospital, Department of Medicine have published new data on obesity and diabetes
December 11th, 2006
Fresh data on obesity and diabetes are presented in the report "The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats. Glitazones are efficient insulin sensitizers that blunt the effects of angiotensin II (ANG II) in the rat. Sodium chloride is another important modulator of the systemic and renal effects of ANG II," scientists writing in the American Journal of Physiology - Endocrinology and Metabolism report. "Whether glitazones interfere with the interaction between sodium and the response to ANG II is not known. Therefore, we investigated the effects of pioglitazone on the relationship between...
Source: Obesity & Diabetes Week (2006-12-11)
|
